Company Data
Prelude Therapeutics Incorporated
Ticker
PRLD
Current Price
$4.44 0.23%
Market Cap
$279.7M
Price Target
Refer to Report
Volume
351.2K
52wk Range
$0.72 - $5.54
Overview
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.